hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06353321, orgStudyIdInfo id: STU-2024-0024, briefTitle: Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-10-01, completionDateStruct date: 2025-10-01, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: University of Texas Southwestern Medical Center, class: OTHER, collaborators name: RefleXion Medical, descriptionModule briefSummary: To qualitatively determine the imaging performance of PET-CT imaging subsystem of the RefleXion X1 System Device in patients undergoing standard-of-care (SOC) \[68Ga\]-PSMA-11 PET-CT using Illuccix on the same day., conditionsModule conditions: Prostate Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: PET-CT imaging subsystem of the RefleXion X1 System Device, outcomesModule primaryOutcomes measure: Qualitative assessment of RefleXion X1 imaging performance with Illuccix PSMA PET imaging agent immediately following a standard of care Illuccix PET/CT, eligibilityModule sex: MALE, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06353308, orgStudyIdInfo id: EA230308, briefTitle: Effectiveness of an Online Intervention Using a Feminist Approach on Gender Equality Promotion and Sexual Violence Prevention in China, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-05-12, primaryCompletionDateStruct date: 2024-02-10, completionDateStruct date: 2024-03-02, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: The University of Hong Kong, class: OTHER, descriptionModule briefSummary: This paper presents the findings of a clustered randomized controlled trial (cRCT) that evaluated the effectiveness of an online feminist sexual health intervention among Chinese young adults, providing insights into the impacts of this innovative approach and contribute to the growing body of literature on feminist interventions for sexual health and equality promotion., conditionsModule conditions: Sexual Violence, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 422, type: ACTUAL, armsInterventionsModule interventions name: Sexual Violence Prevention, interventions name: Sexual health intervention, outcomesModule primaryOutcomes measure: Rape myth acceptance, secondaryOutcomes measure: Sociocultural Attitudes toward Appearance, secondaryOutcomes measure: Sexual Attitudes Scale, secondaryOutcomes measure: Sexual Desire Inventory, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 29 Years, stdAges: ADULT, contactsLocationsModule locations facility: The university of Hong Kong, city: Hong Kong, zip: 000000, country: Hong Kong, geoPoint lat: 22.27832, lon: 114.17469, hasResults: False
protocolSection identificationModule nctId: NCT06353295, orgStudyIdInfo id: 22-38098, secondaryIdInfos id: CO-US-412-6436, type: OTHER_GRANT, domain: Gilead Sciences, briefTitle: Community-based, Peer-delivered PrEP for Female Sex Workers in Rural Uganda: The Peers for PrEP (P4P) Study, acronym: P4P, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-06, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: University of California, San Francisco, class: OTHER, collaborators name: Gilead Sciences, descriptionModule briefSummary: The overall goal of the P4P: Peers for PrEP (pre-exposure prophylaxis) study is to pilot test a peer-led and delivered intervention for biomedical HIV prevention that is tailored to women who engage in sex work in southwestern Uganda. This study will evaluate whether this intervention is feasible, acceptable, and increases uptake of biomedical prevention., conditionsModule conditions: HIV/AIDS, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: A single-arm pilot trial to evaluate a community-based, peer-led and delivered intervention to provide biomedical prevention products (e.g. pre-exposure prophylaxis \[PrEP\] and post-exposure prophylaxis \[PEP\]) for women who engage in sex work in southwestern Uganda. This study will test whether the intervention is feasible, acceptable, and increases biomedical prevention uptake., primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 140, type: ESTIMATED, armsInterventionsModule interventions name: P4P intervention, outcomesModule primaryOutcomes measure: Uptake of biomedical prevention, secondaryOutcomes measure: Feasibility of delivery of the P4P intervention by peers, secondaryOutcomes measure: Acceptability of the P4P intervention, eligibilityModule sex: FEMALE, minimumAge: 15 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Infectious Diseases Research Collaboration, city: Kampala, country: Uganda, contacts name: Jane Kabami, MPH, PhDc, role: CONTACT, phone: +256 312 281-479, email: jkabami@idrc-uganda.org, geoPoint lat: 0.31628, lon: 32.58219, hasResults: False
protocolSection identificationModule nctId: NCT06353282, orgStudyIdInfo id: 24-000795, briefTitle: MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2025-07-01, primaryCompletionDateStruct date: 2026-01-31, completionDateStruct date: 2026-12-31, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: University of California, Los Angeles, class: OTHER, descriptionModule briefSummary: The primary objective of this study is to determine the safety and feasibility of 3,4-methylenedioxymethamphetamine (MDMA) -assisted psychotherapy to treat resistant post-traumatic stress disorder (PTSD). The secondary objectives are the exploration of effectiveness for treatment-resistant PTSD, symptoms of depression, and anxiety symptoms., conditionsModule conditions: PTSD, Post Traumatic Stress Disorder, conditions: Adolescents, conditions: Psychotherapy, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: MDMA, interventions name: Psychotherapy, outcomesModule primaryOutcomes measure: Changes in heart rhythm via Carnation Ambulatory Heart Monitor, primaryOutcomes measure: Changes in blood pressure, primaryOutcomes measure: Change in pulse, primaryOutcomes measure: Change in body temperature, primaryOutcomes measure: Mean change in score of visual analog scale to assess potential for misuse of MDMA, secondaryOutcomes measure: Mean change in PTSD symptom severity via the Child PTSD Symptom Scale, secondaryOutcomes measure: Mean change in PTSD symptom severity via the Clinician-Administered PTSD Scale (CAPS-CA-5), secondaryOutcomes measure: Mean change in depression symptom severity via the Patient Health Questionnaire-9 (PHQ-9)., secondaryOutcomes measure: Mean change in anxiety symptom severity via the Generalized Anxiety Disorder 7-item (GAD-7), eligibilityModule sex: ALL, minimumAge: 16 Years, maximumAge: 17 Years, stdAges: CHILD, contactsLocationsModule locations facility: UCLA Semel Institute for Neuroscience and Human Behavior, city: Los Angeles, state: California, zip: 90095, country: United States, contacts name: Jessica K Jeffrey, MD, MPH, MBA, role: CONTACT, phone: 310-825-5263, email: jjeffrey@mednet.ucla.edu, contacts name: Marc J Weintraub, Ph.D., role: CONTACT, phone: 310-825-1300, email: mjweintraub@mednet.ucla.edu, contacts name: Jessica K Jeffrey, MD, MPH, MBA, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 34.05223, lon: -118.24368, hasResults: False
protocolSection identificationModule nctId: NCT06353256, orgStudyIdInfo id: 300012607, secondaryIdInfos id: UL1TR003096, type: NIH, link: https://reporter.nih.gov/quickSearch/UL1TR003096, secondaryIdInfos id: 24POST1198805, type: OTHER_GRANT, domain: American Heart Association, briefTitle: A Community Health Worker Intervention to Address Preeclampsia, acronym: AW2H, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2025-04-30, completionDateStruct date: 2025-04-30, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: University of Alabama at Birmingham, class: OTHER, collaborators name: American Heart Association, collaborators name: National Center for Advancing Translational Sciences (NCATS), descriptionModule briefSummary: United States maternal mortality and preterm birth rates are among the highest among high-income countries due in part to a combination of racial, regional and socioeconomic disparities in access to care and overall health. The research proposed focuses on adapting and expanding a perinatal community health worker intervention for Black postpartum patients with preeclampsia (PE). Investigators will partner with a community-based organization that trains and deploys community health workers. Investigators will test an intervention for urban and rural Black postpartum patients with PE to 1) enhance blood pressure control postpartum and 2) promote long-term cardiovascular disease prevention for this underserved population. This pilot study will determine if randomizing and implementing a community health worker intervention tailored to pregnant people experiencing preeclampsia is feasible and found to be acceptable by participants., conditionsModule conditions: Preeclampsia Postpartum, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: usual postpartum care, outcomesModule primaryOutcomes measure: Acceptability, eligibilityModule sex: FEMALE, minimumAge: 16 Years, maximumAge: 56 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06353243, orgStudyIdInfo id: STUDY00022901, briefTitle: Bilateral Infant Stimulation Study, acronym: BLISS, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-26, primaryCompletionDateStruct date: 2024-08, completionDateStruct date: 2024-08, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Oregon Health and Science University, class: OTHER, descriptionModule briefSummary: This study will investigate stress that parents of children admitted to the neonatal intensive care unit (NICU) experience. Investigation of a novel intervention of using bilateral alternating stimulation to reduce parental stress and anxiety and increase bonding/attachment in NICU. Evaluate parental stress and feelings of bonding using surveys before and after the intervention. Intervention will be done at neonate's bedside while admitted to the NICU. Vital sign data will be collected as a marker of parent and neonate's stress response during the intervention., conditionsModule conditions: Parent-Child Relations, conditions: Preterm Birth, conditions: Stress Reaction, conditions: Hospitalism in Children, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Bilateral alternating stimulation, outcomesModule primaryOutcomes measure: Parental anxiety, primaryOutcomes measure: Physiologic stress response, primaryOutcomes measure: Parental distress, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Oregon Health and Science University Neonatal Intensive Care Unit, status: RECRUITING, city: Portland, state: Oregon, zip: 97219, country: United States, contacts name: Emily Garavatti, MD, role: CONTACT, phone: 503-494-2634, email: garavatt@ohsu.edu, geoPoint lat: 45.52345, lon: -122.67621, hasResults: False
protocolSection identificationModule nctId: NCT06353230, orgStudyIdInfo id: 0001, briefTitle: Comparison of Sclerotherapy Agents Used for Rectal Prolapse Treatment in Children, acronym: Prolapse, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-10-15, primaryCompletionDateStruct date: 2020-10-14, completionDateStruct date: 2021-04-13, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-15, sponsorCollaboratorsModule leadSponsor name: King Edward Medical University, class: OTHER, descriptionModule briefSummary: Introduction Patients with rectal prolapse are treated with injection sclerotherapy, which is the most often used first-line surgical technique. Injection sclerotherapy has a success rate of 90-100% in youngsters, according to certain studies. Objective To compare the outcome of injection sclerotherapy using 5% Phenol in almond oil, 15% hypertonic saline and 50% dextrose water in the treatment of rectal prolapse in children., conditionsModule conditions: Rectal Prolapse, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Comparison of 5% phenol in almond oil, 15% hypertonic saline and 50% dextrose water for sclerotherapy treatment of rectal prolapse in children., primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: Randomly allocated groupA,B or C by computer generated lottery method.and participants ,care provider and outcome assessor were kept blind by removing the drug name from injection vial, enrollmentInfo count: 93, type: ACTUAL, armsInterventionsModule interventions name: injection 5% phenol in almond oil, interventions name: injection 15% hypertonic saline, interventions name: injection 50% dextrose water, outcomesModule primaryOutcomes measure: Recurrence, secondaryOutcomes measure: fecal incontinence, eligibilityModule sex: ALL, minimumAge: 3 Years, maximumAge: 13 Years, stdAges: CHILD, contactsLocationsModule locations facility: department of pediatric surgery King Edward Medical University, city: Lahore, state: Punjab, zip: 54000, country: Pakistan, geoPoint lat: 31.558, lon: 74.35071, hasResults: False
protocolSection identificationModule nctId: NCT06353191, orgStudyIdInfo id: 19-002566, secondaryIdInfos id: NCI-2024-00943, type: REGISTRY, domain: CTRP (Clinical Trial Reporting Program), secondaryIdInfos id: 19-002566, type: OTHER, domain: Mayo Clinic in Florida, secondaryIdInfos id: P30CA015083, type: NIH, link: https://reporter.nih.gov/quickSearch/P30CA015083, secondaryIdInfos id: R01HL169268, type: NIH, link: https://reporter.nih.gov/quickSearch/R01HL169268, secondaryIdInfos id: R56HL160643, type: NIH, link: https://reporter.nih.gov/quickSearch/R56HL160643, briefTitle: Biomarkers to Predict Cancer Therapy-related Cardiotoxicity, statusModule overallStatus: RECRUITING, startDateStruct date: 2019-05-03, primaryCompletionDateStruct date: 2026-06-01, completionDateStruct date: 2026-06-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Mayo Clinic, class: OTHER, collaborators name: National Cancer Institute (NCI), collaborators name: National Heart, Lung, and Blood Institute (NHLBI), descriptionModule briefSummary: This study evaluates why some cancer patients but not others experience changes in heart function following treatment with chemotherapy., conditionsModule conditions: Hematopoietic and Lymphatic System Neoplasm, conditions: Malignant Solid Neoplasm, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 1000, type: ESTIMATED, armsInterventionsModule interventions name: Non-Interventional Study, outcomesModule primaryOutcomes measure: Collection of biospecimens from patients who developed cardiac toxicity (CRCT) or who are at high risk for developing CRCT, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Mayo Clinic in Arizona, status: RECRUITING, city: Scottsdale, state: Arizona, zip: 85259, country: United States, contacts name: Clinical Trials Referral Office, role: CONTACT, phone: 855-776-0015, email: mayocliniccancerstudies@mayo.edu, contacts name: Myrah Manuel, role: CONTACT, phone: 480-574-3157, email: Manuel.Myrah@mayo.edu, contacts name: Lida A. Mina, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 33.50921, lon: -111.89903, locations facility: Mayo Clinic in Florida, status: RECRUITING, city: Jacksonville, state: Florida, zip: 32224-9980, country: United States, contacts name: Clinical Trials Referral Office, role: CONTACT, phone: 855-776-0015, email: mayocliniccancerstudies@mayo.edu, contacts name: Pamela Williamson, role: CONTACT, phone: 904-953-4694, email: Williamson.Pamela@mayo.edu, contacts name: Nadine Norton, Ph.D., role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 30.33218, lon: -81.65565, locations facility: Mayo Clinic in Rochester, status: SUSPENDED, city: Rochester, state: Minnesota, zip: 55905, country: United States, geoPoint lat: 44.02163, lon: -92.4699, hasResults: False
protocolSection identificationModule nctId: NCT06353178, orgStudyIdInfo id: 20240314, briefTitle: Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers, acronym: BEACON, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-08, primaryCompletionDateStruct date: 2025-02-01, completionDateStruct date: 2025-04-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Color Health, Inc., class: INDUSTRY, descriptionModule briefSummary: Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program., conditionsModule conditions: Cancer, conditions: Caregiving Stress, conditions: Caregiver Burnout, conditions: Survivorship, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants will be randomized to waitlist or intervention group. Those in intervention group will receive the peer program; those on the waitlist will receive it after being on the waitlist for 3 months., primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, maskingDescription: Participants will be notified of a waitlist assignment upon enrolling. Those on the waitlist will receive the intervention after 3 months., enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Cancer Connect Program, outcomesModule primaryOutcomes measure: Quality of Life, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Color Health, status: RECRUITING, city: Burlingame, state: California, zip: 94010, country: United States, geoPoint lat: 37.5841, lon: -122.36608, hasResults: False
protocolSection identificationModule nctId: NCT06353165, orgStudyIdInfo id: CRO-2022-12-BAC-SNF-THA-YPZ, briefTitle: Anti-bacterial Clinical Study on Teeth, Tongue, Cheek, Gum, and Saliva, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-08, primaryCompletionDateStruct date: 2023-04-12, completionDateStruct date: 2023-04-12, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-15, sponsorCollaboratorsModule leadSponsor name: Colgate Palmolive, class: INDUSTRY, descriptionModule briefSummary: This 4-week clinical study was designed to examine the antibacterial efficacy of brushing with a 0.454% stannous fluoride toothpaste with potassium nitrate and pyrophosphate compared to a toothpaste containing 0.76% MFP (marketed as Colgate Cavity Protection Toothpaste) in different regions of the mouth (dental plaque, tongue, cheek, gum surface and in saliva) 12 hours post-brushing (overnight) after 2 and 4 weeks of product use., conditionsModule conditions: Plaque, Dental, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: blinded, primaryPurpose: PREVENTION, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 100, type: ACTUAL, armsInterventionsModule interventions name: Stannous fluoride toothpaste, interventions name: Colgate Dental Cream, outcomesModule primaryOutcomes measure: Whole mouth scores of dental plaque, primaryOutcomes measure: Measurement of total bacterial counts on tongue, primaryOutcomes measure: Measurement of total bacterial counts on cheek, primaryOutcomes measure: Measurement of gingivitis, primaryOutcomes measure: Measurement of total bacterial counts in saliva, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: M U International Oral Science Research, Ltd., city: Bangkok, state: Krung Thep Maha Nakhon, zip: 10250, country: Thailand, geoPoint lat: 13.75398, lon: 100.50144, hasResults: False